How to Interpret the GI360™
Presented by Jeannie Gorman, MS, CCN | August 7, 2024
If your patients suffer from gastrointestinal issues like IBS or IBD, systemic conditions such as celiac disease, cardiovascular or neurological disorders, and even skin or autoimmune diseases, the GI360™ from Doctor's Data could be a game-changer.This webinar will provide an overview of the industry-leading GI360™ stool test. A primary focus will be the rationale for the essential incorporation of complementary methodologies to evaluate gastrointestinal microbes. Other components covered will be the advantages and limitations of PCR-based testing, culture-based/proteomic testing, and susceptibility testing. Additionally, the highly focused microbiome and dysbiosis evaluation will be highlighted regarding published validation and clinical application. Furthermore, the comprehensive array of stool chemistries will be featured in context with the overall evaluation. Case studies will also be presented to illustrate the clinical value of the GI360™.
Learning Objectives:
• Jeannie Gorman, MS, CCN, will explain the test's utilization of advanced technologies like multiplex PCR, MALDI-TOF, and microscopy.
• You will learn how the GI360™ informs the Dysbiosis Index (DI) and Diversity Score (DS) and what these scores mean for your patients.
• You will get practical advice on the stool sample collection process and learn why PCR testing's sensitivity is crucial for accurate results.)
• Plus, tips on follow up testing!Whether you're a healthcare professional or someone interested in gut health, this webinar offers invaluable insights into interpreting the GI360™ test and applying its findings for better health outcomes.
CHAPTERS:
00:00 GI 360 Overview & Objectives
01:03 Clinical Uses of GI Testing
03:44 Ideal Candidates for Gut Testing
05:09 When to Avoid Testing
07:02 Proper Stool Collection Guidelines
08:59 PCR and Culture Methodologies Explained
10:59 Benefits of PCR vs Culture
13:03 Understanding the GI 360 Report
14:53 Disbiosis Index & Diversity Score
16:13 Functional Guilds and Key Findings
17:07 Deep Dive into Beneficial Microbiome
18:47 Important Microbiota Species Explained
20:07 Transition to Pathogen Detection
21:20 Parasitology and Yeast Findings
22:11 Culture Analysis and Dysbiotic Bacteria
23:40 Stool Chemistry and Short Chain Fatty Acids
25:17 Natural & Rx Treatment Options
27:12 Case Study: Female with Chronic Diarrhea
30:29 Interpretation of Microbiome Imbalances
33:05 Inflammation, Immune Markers & Short Chain Fatty Acids
36:04 Treating Candida and Dysbiosis
38:01 Custom Treatment Plan & Retesting
40:00 Patient Recommendations & Dietary Adjustments
42:04 Q&A Session Begins